MedMira is continuously developing more ways to expand on future potentials of its RVF Technology, if this is customer satisfaction, increase of output or supporting regulatory for additional claims.
In collaboration with researchers, Dr. Xu Zhang and Dr. Andrew Carrier at Cape Brenton University, and with the great support of NSBI (Nova Scotia Business Inc - our significant stakeholder), we are pleased to announce the phase 2 development of MedMira’s Lipo-Gold Nanoparticles is fully funded by NSBI. The grant was approved on the 19th of July 2022 and we expect to continue with this project in the coming week.